[1]
B. A. Silva, R. Rauber, R. F. Mion, L. L. Martins, N. Formentini, and V. Guth, “Use of CRISPR-Cas9 in oncology: systematic review of preclinical in vivo studies and phase I clinical trials”, Braz. J. Implantol. Health Sci., vol. 7, no. 9, pp. 723–749, Sep. 2025.